To look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.

Neoadjuvant TreatmentThyroid Cancer

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06959511

Phase 2

The 'SWIVEL' Study (Switch Vs Effects Relief): Effectiveness of a Medication 'Switch' vs Guideline-Directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Researchers have learned that about 50% of women do not finish the standard 5-year breast cancer treatment with an aromatase inhibitor. An aromatase inhibitor …

Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer

~Estimated

~$10 – $6,250

Dartmouth-Hitchcock Medical CenterNCT07071038